Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer
N. Nathan (Paris, France), M. Legendre (Paris, France), E. Filhol-Blin (Paris, France), R. Borie (Paris, France), D. Bouvry (Bobigny, France), C. Kannengiesser (Paris, France), K. Ahmad (Lyon, France), J. Albuisson (Paris, France), N. Allou (Saint Denis de la Réunion, France), K. Borensztajn (Paris, France), A. Butt (Paris, France), B. Copin (Paris, France), V. Cottin (Lyon, France), B. Crestani (Paris, France), J. Dalphin (Besancon, France), F. Dastot Le Moal (Paris, France), C. Delacourt (Lyon, France), P. De Vuyst (Brussels, Belgium), P. Duquesnoy (Paris, France), V. Giraud (Boulogne Billancourt, France), C. Gomez (Marseille Billancourt, France), L. Gouya (Colombes Billancourt, France), V. Nau (Paris, France), H. Nunes (Bobigny, France), C. Picard (Suresnes, France), G. Prevot (Toulouse, France), P. Reix (Lyon, France), M. Reynaud-Gaubert (Marseille, France), J. Traclet (Lyon, France), A. Coulomb L'Hermine (Paris, France), A. Clement (Paris, France), S. Amselem (Paris, France)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Nathan (Paris, France), M. Legendre (Paris, France), E. Filhol-Blin (Paris, France), R. Borie (Paris, France), D. Bouvry (Bobigny, France), C. Kannengiesser (Paris, France), K. Ahmad (Lyon, France), J. Albuisson (Paris, France), N. Allou (Saint Denis de la Réunion, France), K. Borensztajn (Paris, France), A. Butt (Paris, France), B. Copin (Paris, France), V. Cottin (Lyon, France), B. Crestani (Paris, France), J. Dalphin (Besancon, France), F. Dastot Le Moal (Paris, France), C. Delacourt (Lyon, France), P. De Vuyst (Brussels, Belgium), P. Duquesnoy (Paris, France), V. Giraud (Boulogne Billancourt, France), C. Gomez (Marseille Billancourt, France), L. Gouya (Colombes Billancourt, France), V. Nau (Paris, France), H. Nunes (Bobigny, France), C. Picard (Suresnes, France), G. Prevot (Toulouse, France), P. Reix (Lyon, France), M. Reynaud-Gaubert (Marseille, France), J. Traclet (Lyon, France), A. Coulomb L'Hermine (Paris, France), A. Clement (Paris, France), S. Amselem (Paris, France). Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer. 2235
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: